1. Home
  2. LIVE vs BTAI Comparison

LIVE vs BTAI Comparison

Compare LIVE & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

N/A

Current Price

$9.99

Market Cap

30.3M

ML Signal

N/A

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
BTAI
Founded
1968
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
49.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LIVE
BTAI
Price
$9.99
$2.10
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$32.80
AVG Volume (30 Days)
6.5K
658.3K
Earning Date
12-11-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$443,794,000.00
$752,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$544.99
P/E Ratio
$21.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$1.17
52 Week High
$25.88
$9.26

Technical Indicators

Market Signals
Indicator
LIVE
BTAI
Relative Strength Index (RSI) 48.67 51.76
Support Level $9.05 $1.82
Resistance Level $12.49 $2.33
Average True Range (ATR) 1.04 0.17
MACD 0.33 0.05
Stochastic Oscillator 69.44 62.87

Price Performance

Historical Comparison
LIVE
BTAI

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: